Skip to main content
. 2022 Dec 1;67(3):323–329. doi: 10.20945/2359-3997000000547

Table 3. Prevalence of metabolic syndrome criteria according to IDF.

Criteria NFAA (n: 134) Control (n: 68) p
FBG ≥ 100 (mg/dL) or type 2 diabetes story 57.4% (n = 77) 42.6% (n = 29) 0.04
WC (≥80 for female, ≥94 for male (mg/dL) 93.2% (n = 125) 92.6% (n = 63) 0.82
BP ≥ 130/85 or HT story 44.0% (n = 59) 22.1% (n = 15) 0.02
TG ≥ 150 (mg/dL) or treatment story 36.5% (n = 49) 30.7% (n = 16) 0.06
HDL-C < 40 for male, < 50 for female (mg/dL) or treatment story 34.3% (n = 46) 26.9% (n = 17) 0.18

FBG: fasting blood glucose; WC: waist circumference; BP: arterial blood pressure; HT: hypertension; TG: trlyglyceride; HDL-C: HDL cholesterol. Significant p values were shown in bold.